Publications by authors named "Janet North"

Claim this Profile
E
Evaluation of an Adapted Semi-Automated DNA Extraction for Human Salivary Shotgun Metagenomics.
Victoria Meslier, Elisa Menozzi, Aymeric David, Christian Morabito, Sara Lucas Del Pozo, Janet North

Biomolecules· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microparticles in acute coronary syndrome.
Chrysostomos A Mavroudis, Despina Eleftheriou, Ying Hong, Bikash Majumder, Sudheer Koganti, Janet North

Thromb Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-Stage Priming of Allogeneic Natural Killer Cells for the Treatment of Patients with Acute Myeloid Leukemia: A Phase I Trial.
Panagiotis D Kottaridis, Janet North, Maria Tsirogianni, Chloe Marden, Edward R Samuel

PLoS One· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JAK/STAT Signalling in Huntington's Disease Immune Cells.
Ulrike Träger, Anna Magnusson, Nayana Lahiri Swales, Edward Wild, Janet North

PLoS Curr· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model.
Jonathan M Fishman, Mark W Lowdell, Luca Urbani, Tahera Ansari, Alan J Burns, Janet North

Proc Natl Acad Sci U S A· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved accuracy and reproducibility of enumeration of platelet-monocyte complexes through use of doublet-discriminator strategy.
Bikash Majumder, Janet North, Chrysostomos Mavroudis, Roby Rakhit, Mark W Lowdell

Cytometry B Clin Cytom· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells.
Eirini Katodritou, Evangelos Terpos, Janet North, Panagiotis Kottaridis, Evgenia Verrou

Am J Hematol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemic priming of resting NK cells is killer Ig-like receptor independent but requires CD15-mediated CD2 ligation and natural cytotoxicity receptors.
May Sabry, Maria Tsirogianni, Ismail A Bakhsh, Janet North, Janani Sivakumaran

J Immunol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells.
Andrew J Steele, Archibald G Prentice, A Victor Hoffbrand, Birunthini C Yogashangary, Stephen M Hart, Janet M North

Blood· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-primed human natural killer cells lyse NK-resistant tumor targets: evidence of a two-stage process in resting NK cell activation.
Janet North, Ismail Bakhsh, Chloe Marden, Hanna Pittman, Elena Addison

J Immunol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Ligation of CD8alpha on human natural killer cells prevents activation-induced apoptosis and enhances cytolytic activity.
Elena G Addison, Janet North, Ismail Bakhsh, Chloe Marden, Sumaira Haq

Immunology· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective apoptotic killing of malignant hemopoietic cells by antibody-targeted delivery of an amphipathic peptide.
Alexandra J Marks, Margaret S Cooper, Robert J Anderson, Kim H Orchard, Geoffrey Hale, Janet M North

Cancer Res· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geldanamycin and herbimycin A induce apoptotic killing of B chronic lymphocytic leukemia cells and augment the cells' sensitivity to cytotoxic drugs.
Dylan T Jones, Elena Addison, Janet M North, Mark W Lowdell, A Victor Hoffbrand

Blood· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis